Phosphorylation of β-arrestin 2 at Thr383 by MEK underlies β-arrestin-dependent activation of Erk1/2 by GPCRs

  1. Elisabeth Cassier
  2. Nathalie Gallay
  3. Thomas Bourquard
  4. Sylvie Claeysen
  5. Joël Bockaert
  6. Pascale Crépieux
  7. Anne Poupon
  8. Eric Reiter
  9. Philippe Marin  Is a corresponding author
  10. Franck Vandermoere  Is a corresponding author
  1. CNRS, UMR-5203, Institut de Génomique Fonctionnelle, France
  2. INRA, UMR85, Unité Physiologie de la Reproduction et des Comportements, France

Abstract

In addition to their role in desensitization and internalization of G protein-coupled receptors (GPCRs), β-arrestins are essential scaffolds linking GPCRs to Erk1/2 signaling. However, their role in GPCR-operated Erk1/2 activation differs between GPCRs and the underlying mechanism remains poorly characterized. Here, we show that activation of serotonin 5-HT2C receptors, which engage Erk1/2 pathway via a β-arrestin-dependent mechanism, promotes MEK-dependent β-arrestin 2 phosphorylation at Thr383, a necessary step for Erk recruitment to the receptor/β-arrestin complex and Erk activation. Likewise, Thr383 phosphorylation is involved in β-arrestin-dependent Erk1/2 stimulation elicited by other GPCRs such as β2-adrenergic, FSH and CXCR4 receptors, but does not affect the β-arrestin-independent Erk1/2 activation by 5-HT4 receptor. Collectively, these data show that β-arrestin 2 phosphorylation at Thr383 underlies β-arrestin-dependent Erk1/2 activation by GPCRs.

Article and author information

Author details

  1. Elisabeth Cassier

    CNRS, UMR-5203, Institut de Génomique Fonctionnelle, Montpellier, France
    Competing interests
    The authors declare that no competing interests exist.
  2. Nathalie Gallay

    INRA, UMR85, Unité Physiologie de la Reproduction et des Comportements, Nouzilly, France
    Competing interests
    The authors declare that no competing interests exist.
  3. Thomas Bourquard

    INRA, UMR85, Unité Physiologie de la Reproduction et des Comportements, Nouzilly, France
    Competing interests
    The authors declare that no competing interests exist.
  4. Sylvie Claeysen

    CNRS, UMR-5203, Institut de Génomique Fonctionnelle, Montpellier, France
    Competing interests
    The authors declare that no competing interests exist.
  5. Joël Bockaert

    CNRS, UMR-5203, Institut de Génomique Fonctionnelle, Montpellier, France
    Competing interests
    The authors declare that no competing interests exist.
  6. Pascale Crépieux

    INRA, UMR85, Unité Physiologie de la Reproduction et des Comportements, Nouzilly, France
    Competing interests
    The authors declare that no competing interests exist.
  7. Anne Poupon

    INRA, UMR85, Unité Physiologie de la Reproduction et des Comportements, Nouzilly, France
    Competing interests
    The authors declare that no competing interests exist.
  8. Eric Reiter

    INRA, UMR85, Unité Physiologie de la Reproduction et des Comportements, Nouzilly, France
    Competing interests
    The authors declare that no competing interests exist.
  9. Philippe Marin

    CNRS, UMR-5203, Institut de Génomique Fonctionnelle, Montpellier, France
    For correspondence
    philippe.marin@igf.cnrs.fr
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5977-7274
  10. Franck Vandermoere

    CNRS, UMR-5203, Institut de Génomique Fonctionnelle, Montpellier, France
    For correspondence
    franck.vandermoere@igf.cnrs.fr
    Competing interests
    The authors declare that no competing interests exist.

Funding

Fondation pour la Recherche Médicale (Contract Equipe FRM 2009)

  • Elisabeth Cassier
  • Sylvie Claeysen
  • Joël Bockaert
  • Philippe Marin
  • Franck Vandermoere

Agence Nationale de la Recherche (Contract ANR-2011-1619 01)

  • Elisabeth Cassier
  • Nathalie Gallay
  • Thomas Bourquard
  • Sylvie Claeysen
  • Joël Bockaert
  • Pascale Crépieux
  • Anne Poupon
  • Eric Reiter
  • Philippe Marin
  • Franck Vandermoere

Centre National de la Recherche Scientifique

  • Elisabeth Cassier
  • Sylvie Claeysen
  • Joël Bockaert
  • Philippe Marin
  • Franck Vandermoere

Institut National de la Santé et de la Recherche Médicale

  • Elisabeth Cassier
  • Sylvie Claeysen
  • Joël Bockaert
  • Philippe Marin
  • Franck Vandermoere

Université de Montpellier

  • Elisabeth Cassier
  • Sylvie Claeysen
  • Joël Bockaert
  • Philippe Marin
  • Franck Vandermoere

Institut National de la Recherche Agronomique

  • Nathalie Gallay
  • Thomas Bourquard
  • Pascale Crépieux
  • Anne Poupon
  • Eric Reiter

Université François-Rabelais

  • Nathalie Gallay
  • Thomas Bourquard
  • Pascale Crépieux
  • Anne Poupon
  • Eric Reiter

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2017, Cassier et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,698
    views
  • 595
    downloads
  • 54
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Elisabeth Cassier
  2. Nathalie Gallay
  3. Thomas Bourquard
  4. Sylvie Claeysen
  5. Joël Bockaert
  6. Pascale Crépieux
  7. Anne Poupon
  8. Eric Reiter
  9. Philippe Marin
  10. Franck Vandermoere
(2017)
Phosphorylation of β-arrestin 2 at Thr383 by MEK underlies β-arrestin-dependent activation of Erk1/2 by GPCRs
eLife 6:e23777.
https://doi.org/10.7554/eLife.23777

Share this article

https://doi.org/10.7554/eLife.23777

Further reading

    1. Cell Biology
    2. Developmental Biology
    Heungjin Ryu, Kibum Nam ... Jung-Hoon Park
    Research Article

    In most murine species, spermatozoa exhibit a falciform apical hook at the head end. The function of the sperm hook is not yet clearly understood. In this study, we investigate the role of the sperm hook in the migration of spermatozoa through the female reproductive tract in Mus musculus (C57BL/6), using a deep tissue imaging custom-built two-photon microscope. Through live reproductive tract imaging, we found evidence indicating that the sperm hook aids in the attachment of spermatozoa to the epithelium and facilitates interactions between spermatozoa and the epithelium during migration in the uterus and oviduct. We also observed synchronized sperm beating, which resulted from the spontaneous unidirectional rearrangement of spermatozoa in the uterus. Based on live imaging of spermatozoa-epithelium interaction dynamics, we propose that the sperm hook plays a crucial role in successful migration through the female reproductive tract by providing anchor-like mechanical support and facilitating interactions between spermatozoa and the female reproductive tract in the house mouse.

    1. Cancer Biology
    2. Cell Biology
    Kourosh Hayatigolkhatmi, Chiara Soriani ... Simona Rodighiero
    Tools and Resources

    Understanding the cell cycle at the single-cell level is crucial for cellular biology and cancer research. While current methods using fluorescent markers have improved the study of adherent cells, non-adherent cells remain challenging. In this study, we addressed this gap by combining a specialized surface to enhance cell attachment, the FUCCI(CA)2 sensor, an automated image analysis pipeline, and a custom machine learning algorithm. This approach enabled precise measurement of cell cycle phase durations in non-adherent cells. This method was validated in acute myeloid leukemia cell lines NB4 and Kasumi-1, which have unique cell cycle characteristics, and we tested the impact of cell cycle-modulating drugs on NB4 cells. Our cell cycle analysis system, which is also compatible with adherent cells, is fully automated and freely available, providing detailed insights from hundreds of cells under various conditions. This report presents a valuable tool for advancing cancer research and drug development by enabling comprehensive, automated cell cycle analysis in both adherent and non-adherent cells.